Cancer treatment using siRNA to modulate expression of PRDM2/RIZ protein
US12012597B2 · kind B2 · utility
0Cited by
11References
8Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 15, 2022 |
| Grant date | Jun 18, 2024 |
| Priority date | — |
| Expiry date | Sep 15, 2042 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12Y201/01043
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
Inhibitory RNA molecules that specifically inhibit mammalian RIZ2 expression, with therapeutic effect in cell proliferative diseases, such as cancer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.